• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝性脑病的医疗负担。

The Health Care Burden of Hepatic Encephalopathy.

机构信息

Division of Gastroenterology and Hepatology, Henry Ford Health, Detroit, MI, USA.

Division of Gastroenterology and Hepatology, Henry Ford Health, Detroit, MI, USA; Wayne State University, School of Medicine, Detroit, MI, USA.

出版信息

Clin Liver Dis. 2024 May;28(2):265-272. doi: 10.1016/j.cld.2024.01.009. Epub 2024 Feb 12.

DOI:10.1016/j.cld.2024.01.009
PMID:38548438
Abstract

Hepatic encephalopathy-a common and debilitating complication of cirrhosis-results in major health care burden on both patients and caregivers through direct and indirect costs. In addition to risk of falls, inability to work and drive, patients with hepatic encephalopathy often require hospital admission (and often readmission), and many require subacute care following hospitalization. The costs and psychological impact of liver transplantation often ensue. As the prevalence of chronic liver disease increases throughout the United States, the health care burden of hepatic encephalopathy will continue to grow.

摘要

肝性脑病是肝硬化的一种常见且具危害性的并发症,直接和间接费用给患者和照护者都带来了巨大的医疗负担。除了跌倒的风险、丧失工作和驾驶能力之外,肝性脑病患者常常需要住院(而且常常需要再次住院),许多患者在住院后还需要接受亚急性护理。肝移植的费用和心理影响也随之而来。随着美国慢性肝病的患病率不断增加,肝性脑病的医疗负担将继续增加。

相似文献

1
The Health Care Burden of Hepatic Encephalopathy.肝性脑病的医疗负担。
Clin Liver Dis. 2024 May;28(2):265-272. doi: 10.1016/j.cld.2024.01.009. Epub 2024 Feb 12.
2
Increasing Burden of Hepatic Encephalopathy Among Hospitalized Adults: An Analysis of the 2010-2014 National Inpatient Sample.住院成年人肝性脑病负担增加:2010-2014 年全国住院患者样本分析。
Dig Dis Sci. 2019 Jun;64(6):1448-1457. doi: 10.1007/s10620-019-05576-9. Epub 2019 Mar 13.
3
Preventing Readmissions for Hepatic Encephalopathy.预防肝性脑病再入院。
Clin Liver Dis. 2024 May;28(2):345-358. doi: 10.1016/j.cld.2024.01.001. Epub 2024 Jan 30.
4
The burden of hepatic encephalopathy in Latin America.拉丁美洲的肝性脑病负担。
Ann Hepatol. 2011 Jun;10 Suppl 2:S31-5.
5
Burden of compensated and decompensated cirrhosis: real world data from an Italian population-based cohort study.代偿和失代偿肝硬化的负担:来自意大利基于人群队列研究的真实世界数据。
Eur Rev Med Pharmacol Sci. 2021 Jul;25(13):4490-4498. doi: 10.26355/eurrev_202107_26240.
6
Review article: the burden of hepatic encephalopathy.综述文章:肝性脑病的负担
Aliment Pharmacol Ther. 2007 Feb;25 Suppl 1:3-9. doi: 10.1111/j.1746-6342.2006.03215.x.
7
Outcomes after hepatic encephalopathy in population-based cohorts of patients with cirrhosis.肝硬化患者基于人群队列的肝性脑病的预后。
Aliment Pharmacol Ther. 2020 Jun;51(12):1397-1405. doi: 10.1111/apt.15749. Epub 2020 May 3.
8
Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States.美国肝硬化患者再住院的全国估计数和危险因素。
Liver Int. 2019 May;39(5):878-884. doi: 10.1111/liv.14054. Epub 2019 Feb 25.
9
Hepatic encephalopathy.肝性脑病。
Saudi J Gastroenterol. 2012 Sep-Oct;18(5):301-9. doi: 10.4103/1319-3767.101123.
10
Social Impact of Hepatic Encephalopathy.肝性脑病的社会影响。
Clin Liver Dis. 2024 May;28(2):273-285. doi: 10.1016/j.cld.2024.01.011. Epub 2024 Feb 12.

引用本文的文献

1
Drug Utilization of Rifaximin-α in Patients with Hepatic Encephalopathy: Evidence from Real Clinical Practice in Italy.利福昔明-α在肝性脑病患者中的药物利用情况:来自意大利真实临床实践的证据
Medicina (Kaunas). 2025 Jan 26;61(2):221. doi: 10.3390/medicina61020221.
2
Real-World Trends and Future Projections of the Prevalence of Cirrhosis and Hepatic Encephalopathy Among Commercially and Medicare-Insured Adults in the United States.美国商业保险和医疗保险覆盖的成年人中肝硬化和肝性脑病患病率的真实世界趋势及未来预测
Clin Transl Gastroenterol. 2025 Jan 21;16(5). doi: 10.14309/ctg.0000000000000823.
3
Disparities and Outcomes of Physical Restraint Use in Hepatic Encephalopathy: A National Inpatient Assessment.
肝性脑病患者使用身体约束的差异与结局:一项全国住院患者评估
Dig Dis Sci. 2025 Jan;70(1):146-153. doi: 10.1007/s10620-024-08758-2. Epub 2024 Nov 24.